首页|淋巴瘤药物临床研究全流程智能管理

淋巴瘤药物临床研究全流程智能管理

扫码查看
淋巴瘤药物临床研究与 日俱增,各种新兴的药物临床试验模式应运而生,其获益与挑战并存.本研究探索新形势下淋巴瘤药物临床研究智能化管理模式.基于我院现有的科研大数据平台和医院信息系统,结合AI技术和新版GCP等相关法规,我院设计并实施淋巴瘤药物临床研究智能化信息管理模式并不断进行优化,为临床试验全过程实施提供智能化管理支撑,可实现受试者智能筛选、智能标记、智能访视、智能监查、智能质控5个主要功能模块,为药物临床试验受试者和研究人员提供全流程研究工具与服务.2020年3月-2023年6月,我院已在4个淋巴瘤药物临床试验项目中使用智能筛选,12个淋巴瘤项目使用智能质控,利用药物临床试验受试者管理系统进行方案访视在线维护89项淋巴瘤临床试验项目,受试者筛选442例,受试者给药254例,按照受试者智能访视计划访视人数为158,受试者生存随访73例;远程监查在39例淋巴瘤药物临床研究中使用,总监查次数为8 890次.经过初步实践应用,该系统支持决策、辅助执行、规范临床试验流程、保障受试者权益、可提高药物临床试验管理效率和试验质量.初步达到了提质增效的预期目标,为淋巴瘤药物临床研究规范发展创造了有利条件.
Intelligent management of whole process of lymphoma drug clinical research
With the increasing of clinical research on lymphoma drugs,a variety of new clinical trial models have emerged,which have both benefits and challenges.This study explored an intelligent management model for lymphoma drug clinical research.Based on the existing scientific research big data platform and hospital information system of our hospital,combined with AI technology and the new version of GCP and other relevant regulations,an intelligent information management model was designed and implemented for clinical research of lymphoma drugs and continuously optimized,providing intelligent management support for the whole process of clinical trial implementation.It contains five main function modules:intelligent screening of subjects,intelligent marking,intelligent visiting,intelligent monitoring and intelligent quality control.This model provides full process research tools and services for drug clinical trial subjects and researchers.From March 2020 to June 2023,our hospital had used intelligent screening in four lymphoma drug clinical trial projects and intelligent quality control in 12 lymphoma projects,and used drug clinical trial subject management system to conduct protocol visits and online maintenance of 89 lymphoma clinical trial projects,with 442 subjects screened and 254 subjects administered with drugs.According to the intelligent visit plan,158 subjects were interviewed,and 73 subjects were followed up.Remote monitoring was used in 39 clinical studiesof lymphoma drugs,with 8 890 visits.After the initial practice and application,the system supports decision-making and auxiliary execution,standardizes the clinical trial process,protects the rights and interests of the subjects,and can improve the management efficiency and trial quality of drug clinical trials.It has initially achieved the expected goal of improving the quality and efficiency,and created favorable conditions for the standardized development of clinical research on lymphoma drugs.

drug clinical studyintelligentlymphomamanagement

江旻、傅志英、赵淑华、袁延楠、刘晓红

展开 >

北京大学肿瘤医院暨北京市肿瘤防治研究所国家药物临床试验机构消化系肿瘤整合防治全国重点实验室,北京 100142

北京大学肿瘤医院暨北京市肿瘤防治研究所国家药物临床试验机构恶性肿瘤转化研究北京市重点实验室,北京 100142

药物临床研究 智能化 淋巴瘤 管理

北京市卫生健康和科技成果适宜技术推广项目医管中心培育计划

BHTPP2022057PG2023018

2024

中国新药杂志
中国医药科技出版社 中国医药集团总公司 中国药学会

中国新药杂志

CSTPCD北大核心
影响因子:1.039
ISSN:1003-3734
年,卷(期):2024.33(6)
  • 21